In Singapore, Chloe Ng struggled with severe eczema, leading to open wounds on her fingers. After years of trying various treatments, she found relief through new therapies at the National Skin Centre in 2021.
Recent studies have revealed promising signals that could help in the fight against the novel coronavirus. These discoveries open new avenues in medical research at a critical time as the world continues to grapple with the pandemic's effects.
Biogen, a company specializing in drug development, has announced its acquisition of Apellis Pharmaceuticals for <strong>$5.6 billion</strong>. This move aims to expand Biogen's capabilities in treating kidney diseases, addressing the growing need for effective therapies.
Merck & Co. is in advanced talks to acquire Turners Pharmaceuticals, a move aimed at strengthening its portfolio of drugs and treatments. This acquisition reflects Merck's strategy to expand its presence in the global pharmaceutical market.